Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
Status:
Completed
Trial end date:
2020-03-03
Target enrollment:
Participant gender:
Summary
This is the first study in humans to evaluate the effectiveness of SJP-0132 in the treatment
of dry eye disease. This study will evaluate the safety, tolerability, efficacy, and
pharmacokinetics of single- and multiple-dose regimens of SJP-0132 in subjects with dry eye
disease